Chemoinformaics analysis of 4-METHYLDIBENZOTHIOPHENE
| Molecular Weight | 198.29 | nRot | 0 |
| Heavy Atom Molecular Weight | 188.21 | nRig | 15 |
| Exact Molecular Weight | 198.05 | nRing | 3 |
| Solubility: LogS | -6.197 | nHRing | 1 |
| Solubility: LogP | 4.876 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 2 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 15 |
| nHA | 1 | APOL | 31.2779 |
| nHD | 0 | BPOL | 12.4921 |
| QED | 0.503 |
| Synth | 1.802 |
| Natural Product Likeliness | -1.359 |
| NR-PPAR-gamma | 0.976 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.617 |
| MDCK | 0.0000136 |
| BBB | 0.51 |
| PPB | 0.977458 |
| VDSS | 2.196 |
| FU | 0.00891944 |
| CYP1A2-inh | 0.985 |
| CYP1A2-sub | 0.399 |
| CYP2c19-inh | 0.955 |
| CYP2c19-sub | 0.243 |
| CYP2c9-inh | 0.659 |
| CYP2c9-sub | 0.898 |
| CYP2d6-inh | 0.51 |
| CYP2d6-sub | 0.924 |
| CYP3a4-inh | 0.49 |
| CYP3a4-sub | 0.209 |
| CL | 7.663 |
| T12 | 0.06 |
| hERG | 0.024 |
| Ames | 0.801 |
| ROA | 0.044 |
| SkinSen | 0.944 |
| Carcinogencity | 0.858 |
| EI | 0.997 |
| Respiratory | 0.286 |
| NR-Aromatase | 0.874 |
| Antiviral | No |
| Prediction | 0.606617 |